header
For eligible patients with commercial insurance*

Concerned about paying for treatment?
Weʼre here to help.

You could pay as little as $25 per prescription of NINLARO

At Takeda Oncology, we are committed to helping you get access to your prescribed medicines whenever possible.
If you have commercial insurance and are concerned about your ability to pay for your medication costs, you may qualify for
the NINLARO Co-Pay Assistance Program.

To get started, please select the option that best describes you.

If you are already enrolled in the program but were unable to take advantage of the savings,
you may be eligible to receive a rebate. Please visit the McKesson Patient Rebate Online Portal:
patientrebateonline.com

*For example, coverage through an HMO or PPO provided by your employer.
Program participants who meet all Program eligibility requirements will pay the first Twenty-five Dollars ($25.00) of their co-pay amount and Takeda will pay the remaining co-pay or co-insurance for each NINLARO® (ixazomib) prescription, up to a maximum of Twenty-five Thousand Dollars ($25,000.00) annually per patient. Program participants will be responsible for any remaining co-pay or co-insurance balance for each prescription. Eligible patients will be eligible for the co-pay assistance up to the maximum amount for a period of twelve (12) months, which begins when a patient enrolls and ends twelve (12) months later. Patients must re-enroll every twelve (12) months in order to maintain eligibility. Restrictions may apply.